The organizational principles of de-differentiated topographic maps in somatosensory cortex

  1. Peng Liu
  2. Anastasia Chrysidou
  3. Juliane Doehler
  4. Martin Hebart
  5. Thomas Wolbers
  6. Esther Kuehn  Is a corresponding author
  1. Otto-von-Guericke University Magdeburg, Germany
  2. Max Planck Institute for Human Cognitive and Brain Sciences, Germany
  3. German Center for Neurodegenerative Diseases (DZNE), Germany

Abstract

Topographic maps are a fundamental feature of cortex architecture in the mammalian brain. One common theory is that the de-differentiation of topographic maps links to impairments in everyday behavior due to less precise functional map readouts. Here, we tested this theory by characterizing de-differentiated topographic maps in primary somatosensory cortex (SI) of younger and older adults by means of ultra-high resolution functional magnetic resonance imaging together with perceptual finger individuation and hand motor performance. Older adults' SI maps showed similar amplitude and size to younger adults' maps, but presented with less representational similarity between distant fingers. Larger population receptive field sizes in older adults' maps did not correlate with behavior, whereas reduced cortical distances between D2 and D3 related to worse finger individuation but better motor performance. Our data uncover the drawbacks of a simple de-differentiation model of topographic map function, and motivate the introduction of feature-based models of cortical reorganization.

Data availability

Behavioral and MRI data have been deposited in dryad (doi:10.5061/dryad.mgqnk98x8)

The following data sets were generated

Article and author information

Author details

  1. Peng Liu

    Institute for Cognitive Neurology and Dementia Research, Otto-von-Guericke University Magdeburg, Magdeburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  2. Anastasia Chrysidou

    Institute for Cognitive Neurology and Dementia Research, Otto-von-Guericke University Magdeburg, Magdeburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Juliane Doehler

    Institute for Cognitive Neurology and Dementia Research, Otto-von-Guericke University Magdeburg, Magdeburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Martin Hebart

    Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Thomas Wolbers

    RG Aging & Cognition, German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Esther Kuehn

    Institute for Cognitive Neurology and Dementia Research, Otto-von-Guericke University Magdeburg, Magdeburg, Germany
    For correspondence
    esther.kuehn@dzne.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3169-1951

Funding

Center for Behavioral Brain Sciences (ESIF/EFRE 2014-2020; FKZ: ZS/2016/04/78113)

  • Esther Kuehn

German Research Foundation (KU 3711/2-1,project number: 423633679)

  • Peng Liu
  • Juliane Doehler

Else Kroener Fresenius Stiftung (2019-A03)

  • Anastasia Chrysidou

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Peter Kok, University College London, United Kingdom

Ethics

Human subjects: All participants were paid for their attendance and written informed consent for participation and data handling was received from all participants before starting the experiment. The study was approved by the Ethics committee of the Otto-von-Guericke University Magdeburg (68/16).

Version history

  1. Received: June 16, 2020
  2. Accepted: May 17, 2021
  3. Accepted Manuscript published: May 18, 2021 (version 1)
  4. Version of Record published: June 8, 2021 (version 2)

Copyright

© 2021, Liu et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,464
    Page views
  • 206
    Downloads
  • 8
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Peng Liu
  2. Anastasia Chrysidou
  3. Juliane Doehler
  4. Martin Hebart
  5. Thomas Wolbers
  6. Esther Kuehn
(2021)
The organizational principles of de-differentiated topographic maps in somatosensory cortex
eLife 10:e60090.
https://doi.org/10.7554/eLife.60090

Share this article

https://doi.org/10.7554/eLife.60090

Further reading

    1. Neuroscience
    Kiwamu Kudo, Kamalini G Ranasinghe ... Srikantan S Nagarajan
    Research Article

    Alzheimer’s disease (AD) is characterized by the accumulation of amyloid-β and misfolded tau proteins causing synaptic dysfunction, and progressive neurodegeneration and cognitive decline. Altered neural oscillations have been consistently demonstrated in AD. However, the trajectories of abnormal neural oscillations in AD progression and their relationship to neurodegeneration and cognitive decline are unknown. Here, we deployed robust event-based sequencing models (EBMs) to investigate the trajectories of long-range and local neural synchrony across AD stages, estimated from resting-state magnetoencephalography. The increases in neural synchrony in the delta-theta band and the decreases in the alpha and beta bands showed progressive changes throughout the stages of the EBM. Decreases in alpha and beta band synchrony preceded both neurodegeneration and cognitive decline, indicating that frequency-specific neuronal synchrony abnormalities are early manifestations of AD pathophysiology. The long-range synchrony effects were greater than the local synchrony, indicating a greater sensitivity of connectivity metrics involving multiple regions of the brain. These results demonstrate the evolution of functional neuronal deficits along the sequence of AD progression.

    1. Medicine
    2. Neuroscience
    Luisa Fassi, Shachar Hochman ... Roi Cohen Kadosh
    Research Article

    In recent years, there has been debate about the effectiveness of treatments from different fields, such as neurostimulation, neurofeedback, brain training, and pharmacotherapy. This debate has been fuelled by contradictory and nuanced experimental findings. Notably, the effectiveness of a given treatment is commonly evaluated by comparing the effect of the active treatment versus the placebo on human health and/or behaviour. However, this approach neglects the individual’s subjective experience of the type of treatment she or he received in establishing treatment efficacy. Here, we show that individual differences in subjective treatment - the thought of receiving the active or placebo condition during an experiment - can explain variability in outcomes better than the actual treatment. We analysed four independent datasets (N = 387 participants), including clinical patients and healthy adults from different age groups who were exposed to different neurostimulation treatments (transcranial magnetic stimulation: Studies 1 and 2; transcranial direct current stimulation: Studies 3 and 4). Our findings show that the inclusion of subjective treatment can provide a better model fit either alone or in interaction with objective treatment (defined as the condition to which participants are assigned in the experiment). These results demonstrate the significant contribution of subjective experience in explaining the variability of clinical, cognitive, and behavioural outcomes. We advocate for existing and future studies in clinical and non-clinical research to start accounting for participants’ subjective beliefs and their interplay with objective treatment when assessing the efficacy of treatments. This approach will be crucial in providing a more accurate estimation of the treatment effect and its source, allowing the development of effective and reproducible interventions.